58 related articles for article (PubMed ID: 8099136)
1. MDR1 expression in human leukemia-lymphoma cell lines.
Metge K; Steube K; Uphoff CC; Gignac SM; Drexler HG
Leukemia; 1993 Jun; 7(6):896-7. PubMed ID: 8099136
[TBL] [Abstract][Full Text] [Related]
2. Mdr1 gene expression in childhood acute lymphoblastic leukemias and lymphomas: a critical evaluation by four techniques.
Brophy NA; Marie JP; Rojas VA; Warnke RA; McFall PJ; Smith SD; Sikic BI
Leukemia; 1994 Feb; 8(2):327-35. PubMed ID: 7905944
[TBL] [Abstract][Full Text] [Related]
3. Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression.
Marie JP; Faussat-Suberville AM; Zhou D; Zittoun R
Leukemia; 1993 Jun; 7(6):825-31. PubMed ID: 8099135
[TBL] [Abstract][Full Text] [Related]
4. Expression of multidrug resistance gene (MDR-1) in human normal leukocytes.
Damiani D; Michieli M; Michelutti A; Geromin A; Raspadori D; Fanin R; Savignano C; Giacca M; Pileri S; Mallardi F
Haematologica; 1993; 78(1):12-7. PubMed ID: 8098310
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of anionic glutathione-S-transferase (GST pi) and multidrug resistance (mdr1) genes in acute myeloid and lymphoid leukemias.
Russo D; Marie JP; Zhou DC; Faussat AM; Delmer A; Maisonneuve L; Ngoc LH; Baccarani M; Zittoun R
Leukemia; 1994 May; 8(5):881-4. PubMed ID: 7910222
[TBL] [Abstract][Full Text] [Related]
6. Detection of multidrug resistance markers, P-glycoprotein and mdr1 mRNA, in human leukemia cells.
Tsuruo T; Sugimoto Y; Hamada H; Roninson I; Okumura M; Adachi K; Morishima Y; Ohno R
Jpn J Cancer Res; 1987 Dec; 78(12):1415-9. PubMed ID: 2892823
[TBL] [Abstract][Full Text] [Related]
7. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance gene transcript level, and P-glycoprotein expression in paediatric malignant mesenchymal tumours.
McDowell H; Peuchmaur M; Dominici C; Flamant F
Anticancer Res; 1993; 13(5C):1863-6. PubMed ID: 7903523
[TBL] [Abstract][Full Text] [Related]
9. Effect of differentiating agents on modulation of MDR1 gene expression in multidrug-resistant hematopoietic HL60/DNR cell line.
Zhou DC; Marie JP; Maisonneuve L; Faussat-Suberville AM; Zittoun R
Exp Hematol; 1993 Jun; 21(6):779-84. PubMed ID: 8099018
[TBL] [Abstract][Full Text] [Related]
10. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.
Gruss HJ; DaSilva N; Hu ZB; Uphoff CC; Goodwin RG; Drexler HG
Leukemia; 1994 Dec; 8(12):2083-94. PubMed ID: 7528856
[TBL] [Abstract][Full Text] [Related]
11. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists.
Chaudhary PM; Roninson IB
Oncol Res; 1992; 4(7):281-90. PubMed ID: 1360276
[TBL] [Abstract][Full Text] [Related]
12. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells.
Zhao JY; Ikeguchi M; Eckersberg T; Kuo MT
Endocrinology; 1993 Aug; 133(2):521-8. PubMed ID: 8102093
[TBL] [Abstract][Full Text] [Related]
13. Genes amplified and overexpressed in human multidrug-resistant cell lines.
Van der Bliek AM; Baas F; Van der Velde-Koerts T; Biedler JL; Meyers MB; Ozols RF; Hamilton TC; Joenje H; Borst P
Cancer Res; 1988 Nov; 48(21):5927-32. PubMed ID: 2901906
[TBL] [Abstract][Full Text] [Related]
14. Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines.
Verschuren MC; Comans-Bitter WM; Kapteijn CA; Mason DY; Brouns GS; Borst J; Drexler HG; van Dongen JJ
Leukemia; 1993 Dec; 7(12):1939-47. PubMed ID: 8255092
[TBL] [Abstract][Full Text] [Related]
15. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
Baas F; Jongsma AP; Broxterman HJ; Arceci RJ; Housman D; Scheffer GL; Riethorst A; van Groenigen M; Nieuwint AW; Joenje H
Cancer Res; 1990 Sep; 50(17):5392-8. PubMed ID: 1974823
[TBL] [Abstract][Full Text] [Related]
16. Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods.
Zhou DC; Marie JP; Suberville AM; Zittoun R
Leukemia; 1992 Sep; 6(9):879-85. PubMed ID: 1355575
[TBL] [Abstract][Full Text] [Related]
17. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer.
Campling BG; Young LC; Baer KA; Lam YM; Deeley RG; Cole SP; Gerlach JH
Clin Cancer Res; 1997 Jan; 3(1):115-22. PubMed ID: 9815546
[TBL] [Abstract][Full Text] [Related]
18. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
19. Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines.
Meierhoff G; Dehmel U; Gruss HJ; Rosnet O; Birnbaum D; Quentmeier H; Dirks W; Drexler HG
Leukemia; 1995 Aug; 9(8):1368-72. PubMed ID: 7643626
[TBL] [Abstract][Full Text] [Related]
20. Relationship between p53 gene mutations and multidrug resistance (mdr1) gene expression in myelodysplastic syndromes.
Preudhomme C; Lepelley P; Vachee A; Soenen V; Quesnel B; Cosson A; Fenaux P
Leukemia; 1993 Nov; 7(11):1888-90. PubMed ID: 7901457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
